High-capacity adenoviral vectors for gene transfer: reduced toxicity and reduced cell-cycle dysregulation
U. Liebers, B. Schmidt, S. Kochanek, A. Schumacher, G. Wolff, C. Witt (Berlin, Cologne, Germany)
Source: Annual Congress 2002 - Lung cancer biology
Session: Lung cancer biology
Session type: Oral Presentation
Number: 225
Abstract Adenoviral vectors are the most important vehicles for gene therapy trials in lung cancer. First-generation adenoviral vectors are known to cause immune reactions and cell cycle disturbances due to expression of viral proteins. New [dsquote]high-capacity[dsquote] (hc) vectors have all viral coding sequences removed to reduce these reactions in the host organism. In our study we compared a first-generation with two hc-vectors (GS47 and FK7) with regard to cell damage, induction of apoptosis and cell cycle disorder in vitro. Cellular damage was detected in hepatocytes measuring LDH, GOT and GPT. Annexin V and propidium iodide stainings of colorectal cancer cells (LoVo) were used for analysis of apoptotic changes. In the same cells we performed flow cytometric cell cycle analysis. Higher levels of LDH, GOT and GPT were found after transfection with first-generation vectors vs. hc-vectors indicating cellular damage. Apoptotic changes were detected after first-generation but not after hc-vector transfection comparing with controls. These differences were also found on the cell cycle level. Cells accumulated in G2/M-phase after first-generation vector while cell cycle distribution was identical after hc-vector and buffer. Our results suggest that high capacity vectors have advantages over first-generation vectors in terms of toxicity and interference with the host cell.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Liebers, B. Schmidt, S. Kochanek, A. Schumacher, G. Wolff, C. Witt (Berlin, Cologne, Germany). High-capacity adenoviral vectors for gene transfer: reduced toxicity and reduced cell-cycle dysregulation. Eur Respir J 2002; 20: Suppl. 38, 225
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Effect of co-expression of p21waf1/cip1 with a second transgene in adenoviral vectors Source: Eur Respir J 2007; 30: Suppl. 51, 133s Year: 2007
Co-expression of p21Waf1/Cip1 improves adenoviral vector-mediated transgene expression Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008
Comparison of the downregulation of AQP5 gene expression by synthetic siRNA and vector-based shRNA Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
High transfection efficiency and sustained transgene expression in rat lung Source: Eur Respir J 2002; 20: Suppl. 38, 339s Year: 2002
A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations Source: Eur Respir J, 56 (5) 2000205; 10.1183/13993003.00205-2020 Year: 2020
Effects of adenoviral gene transfer of mutated IκBα, a novel inhibitor of NF-κB, on human monocyte-derived dendritic cells Source: Eur Respir J 2006; 28: Suppl. 50, 759s Year: 2006
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth in vivo by retrovirus-mediated gene transfer Source: Annual Congress 2002 - Thoracic oncology: biology Year: 2002
Decreased expression of DNA synthesis repair recombination proteins in lungs of senescence accelerated mouse (SAM) Source: Eur Respir J 2003; 22: Suppl. 45, 73s Year: 2003
Targeted adenoviral gene transfer of wild type (wt) BMPR2 attenuates hypoxic pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 238s Year: 2005
Electroporation mediated gene transfer of hepatocyte growth factor reduces bleomycin induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005
Efficient lentiviral vector transduction in 3-D human fetal airway epithelium Source: Annual Congress 2002 - Molecular mechanisms and signalling pathways in airway epithelial cells Year: 2002
Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
shRNAs significantly reduce the replication of RSV in vitro Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011
Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
Cloning, expression and purification of a recombinant lipid transfer protein and an αβ-gliadin from wheat: determination of the diagnostic impact by specific IgE-measurements Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009
Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009
Modification of gene expression and increase in alpha-1-antitrypsin (α1 AT) secretion after homologous recombination in α1 AT deficient monocytes Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007
Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK / mitochondrial pathway Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008